Still confused about PrEP? Don't know what to make of the controversy surrounding it?
Sign up for next week's webinar!
In response to recent news from the FDA regarding the use of the drug Truvada for prevention, Mapping Pathways, AIDS United and the AIDS Foundation of Chicago are presenting a webinar focusing on the ARV-based strategy PrEP (pre-exposure prophylaxis.)
Please join us on Tuesday, June 19th at 3:00 pm EST for this webinar by emailing zfellows1@aidsunited.org to register.
On May 10, the FDA Antiviral Drug Advisory Committee strongly recommended that emtricitabine/tenofovir disoproxil fumarate (TDF/FTC or Truvada) be approved for use as pre-exposure prophylaxis (PrEP) among sexually active adult men and women particularly gay men and other MSM, serodiscordant heterosexual couples, and other individuals at high risk. It is likely the FDA will follow the committees recommendations and issue a new prevention indication for the use of Truvada by mid-September.
While doctors have been able to prescribe Truvada off label for the prevention of HIV, this new indication will make it official and allow for greater access.
Categorized under Prevention.
By Diego Roman, Communications Specialist
August 18th marks the...
Read more...
By Aleah Vega, Editorial Intern
“My only bleedin’ hope is for the folks...
Read more...
By Livvie Avrick, Digital Communications Manager
Frank Morreale is an artist and advocate...
Read more...
By Livvie Avrick, Digital Communications Manager
“We’re...
Read more...
By Tyline Burgess, Communications Manager, AFC
Johnny Pitts has faced numerous...
Read more...
HUB providing access point to health care and support for migrants who are starting their new lives...
Read more...
El HUB brinda un punto de acceso a la atención médica y apoyo para los migrantes que inician...
Read more...
AIDS Foundation Chicago (AFC) invites you to Show Up and Show Out with us at AIDS Run & Walk Chicago...
Read more...
By Tyline Burgess, Communications Manager, AFC
CHICAGO, IL – This year’s...
Read more...